J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 31.74 CNY 1.18% Market Closed
Market Cap: 25.6B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Jafron Biomedical Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jafron Biomedical Co Ltd
Cash Equivalents Peer Comparison

Comparables:
A
688617
J
002223
300760
L
300003
688271

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash Equivalents
ÂĄ6m
CAGR 3-Years
N/A
CAGR 5-Years
-64%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash Equivalents
ÂĄ1.7B
CAGR 3-Years
-35%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash Equivalents
ÂĄ178.4k
CAGR 3-Years
109%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jafron Biomedical Co Ltd's Cash Equivalents?
Cash Equivalents
6m CNY

Based on the financial report for Jun 30, 2024, Jafron Biomedical Co Ltd's Cash Equivalents amounts to 6m CNY.

What is Jafron Biomedical Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-64%

Over the last year, the Cash Equivalents growth was -51%.

Back to Top